Duke scientists identify antibodies in HIV immune response Duke Chronicle Researchers found the difference between the two trials by specifying a subclass of antibodies linked to HIV elimination and decreased risk of infection in RV144 vaccines. Identifying this subclass of antibodies, called IgG3, could help develop future ... |
